Pay in 4 interest-free payments of $7.06 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
Nanomaterials have great potential in combining chemotherapy with gene therapy for oral cancer, overcoming the limitations of traditional treatments while offering precise and effective therapeutic strategies
Lower-dose treatment might one day suit certain patients, but she said, "Researchers need strong clinical trials first." She outlined what would have to come together: studies testing lower doses directly rather than in theory, proof that the results hold up over years without significant weight re-gain, a clearer picture of who benefits most, consistent manufacturing standards, and regulatory review of the evidence
No other significant correlations were identified in either group, for either Gln/Glu or Glu/GABA ratios
in Biomimetic and Bioinspired Membranes for New Frontiers in Sustainable Water Treatment Technology (IntechOpen, 2017)
At the end of 2022, Sosei Heptares had announced that its long-term collaboration with Pfizer had advanced the first candidate drug, Lotiglipron (PF-07081532), to Phase 2 clinical trials
